PMID: 1100305Sep 1, 1975

Pharmacokinetics of indomethacin

Clinical Pharmacology and Therapeutics
G AlvánL Palmér

Abstract

Plasma concentrations of indomethacin have been studied in 5 healthy volunteers after single and multiple doses (25 mg intravenously [iv], 25, 50, and 100 mg orally, 100 mg rectally, and 25 mg three times daily [tid]. In 8 other normal subjects and in 5 patients a 50-mg oral dose of indomethacin was given and the indomethacin concentration was followed from 8 to 32 hr after dosing. All analyses were carried out using a new mass fragmentographic method. After oral and rectal doses the plasma decay of indomethacin was biphasic, and the data were interpreted according to a 2-compartment open model. The half-life of the beta-phase varied between 2.6 and 11.2 hr. The volume of distribution ranged from 0.34 to 1.57 L/kg and the plasma clearance from 0.044 to 0.109 L/kg/hr. There was no evidence of dose-dependent elimination. Indomethacin was rapidly and well absorbed after oral dosing with peak plasma concentrations within 2 hr. Comparison with the area under the curve (AUC) after iv dosing indicated complete bioavailability. The AUC after rectal dosing indicated complete bioavailability, but the rate of absorption was slower than after oral administration. Indomethacin, 25 mg three times daily, was also given for 9 days to the same ...Continue Reading

Citations

Jan 1, 1978·Australian and New Zealand Journal of Medicine·G D Champion, G G Graham
Nov 1, 1979·European Journal of Clinical Pharmacology·A GrahnénA Rosén
Aug 1, 1991·Acta Anaesthesiologica Scandinavica·I TigerstedtP J Neuvonen
Jan 1, 1990·European Journal of Clinical Pharmacology·B BannwarthA Gaucher
Jan 1, 1987·Acta Orthopaedica Scandinavica. Supplementum·C A Carlstedt
Jan 1, 1986·Journal of Toxicology. Clinical Toxicology·T M SheehanJ A Vale
Jan 1, 1986·European Journal of Clinical Pharmacology·B Terhaag, U Hermann
Apr 1, 1985·Acta Pharmacologica Et Toxicologica·O Thulesius, M Angelo-Khattar
Dec 1, 1986·British Journal of Clinical Pharmacology·B LundR B Andersen
Jun 1, 1985·Clinical Rheumatology·J P Famaey
Oct 1, 1980·The Journal of Pharmacy and Pharmacology·J C McElnay, P F D'Arcy
Dec 16, 1983·Pharmaceutisch Weekblad. Scientific Edition·J H JonkmanA Holtkamp
Nov 1, 1983·Pharmacotherapy·E S Waller
Jan 1, 1981·Scandinavian Journal of Rheumatology. Supplement·M L OrmeT Littler
Oct 1, 1980·British Journal of Clinical Pharmacology·N BaberT Littler
Jan 1, 1982·Scandinavian Journal of Urology and Nephrology·J G Sjödin, D Holmlund
Oct 1, 1993·Clinical Autonomic Research : Official Journal of the Clinical Autonomic Research Society·K P DavyW G Herbert
Nov 21, 2008·Clinical and Experimental Hypertension : CHE·Fiorenzo MigniniValentino Streccioni
Oct 22, 2013·Alimentary Pharmacology & Therapeutics·V S AkshintalaV K Singh
Feb 13, 2016·Headache·Sylvia Lucas
Jan 1, 1988·Clinical and Experimental Hypertension. Part A, Theory and Practice·M P Cinquegrani, C S Liang
May 1, 1994·Acta Anaesthesiologica Scandinavica·D GraceW McCaughey
Aug 1, 1987·Clinical and Experimental Pharmacology & Physiology·W P AndersonA I Gilchrist
Oct 23, 1997·Journal of Neurotrauma·M R HarriganB L Neudeck
Aug 1, 1982·British Journal of Clinical Pharmacology·K R AdamsM L Orme
Dec 1, 1984·Drug Intelligence & Clinical Pharmacy·J A Green
Jun 1, 1984·Acta Orthopaedica Scandinavica·H TörnkvistO S Nilsson
Jan 1, 1983·Current Medical Research and Opinion·P WilliamsM J VandenBurg
Jan 11, 2000·Clinical Obstetrics and Gynecology·A E Hearne, D A Nagey
Sep 10, 1998·Journal of Veterinary Pharmacology and Therapeutics·E VinagreT Encinas
Oct 29, 2004·Clinical Pharmacokinetics·Vassilis TsatsarisBruno Carbonne
Dec 14, 2007·International Journal of Cancer. Journal International Du Cancer·Jeong Hong KimKyung-Su Kim
May 31, 2006·Biopharmaceutics & Drug Disposition·Yuji ManoHidetaka Kamimura
Feb 2, 2011·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Tsuneo DeguchiTakashi Izumi
Apr 2, 2014·Journal of Veterinary Internal Medicine·T L HillA T Blikslager
Feb 5, 2014·Clinical Pharmacokinetics·Erik RyttingMahmoud S Ahmed
Oct 1, 1979·European Journal of Clinical Investigation·E SudmannJ Mørland
Aug 1, 1984·The Journal of Pharmacy and Pharmacology·H Suryakusuma, H W Jun
Aug 1, 1989·Pharmacology & Toxicology·K T OlkkolaR Korpela
Jan 1, 1989·European Journal of Clinical Pharmacology·L O EriksonA Melander
Jan 1, 1989·Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society·J C KellerE St Mary
Jan 1, 1981·Drug Metabolism Reviews·M N CayenD Dvornik
Aug 1, 1992·Anaesthesia and Intensive Care·S Crocker, M Paech
Sep 14, 2001·Journal of Veterinary Pharmacology and Therapeutics·J C BoggioQ McKellar
Jun 1, 1980·European Journal of Clinical Pharmacology·R EkstrandB Sarby
Feb 1, 1996·Journal of Veterinary Pharmacology and Therapeutics·C CristofolM Arboix
Jan 11, 2014·Birth Defects Research. Part B, Developmental and Reproductive Toxicology·Ruud Rg BuetersMichiel F Schreuder
Jan 1, 1982·European Journal of Clinical Pharmacology·H BechgaardT Taylor
Dec 1, 1979·Acta Orthopaedica Scandinavica·E Sudmann, G Bang
Jan 1, 1992·European Journal of Clinical Pharmacology·J C McElnayF S Walker
Dec 1, 1986·Drug Intelligence & Clinical Pharmacy·V A SkoutakisM C Meyer
Jan 1, 1984·Drug Intelligence & Clinical Pharmacy·R S Porter
Jan 1, 1987·Scandinavian Journal of Rheumatology. Supplement·E MoilanenH Vapaatalo
Aug 18, 1999·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·T RapanosJ Kay
Feb 1, 1982·Acta Orthopaedica Scandinavica·E SudmannJ Hald
Nov 12, 1981·The New England Journal of Medicine·P L FriedmanW Grossman
Dec 7, 2005·Pediatric Nephrology : Journal of the International Pediatric Nephrology Association·Nancy ChenGideon Koren
Apr 4, 2003·The Journal of Bone and Joint Surgery. American Volume·K Daniel RiewYong Zhu
Feb 21, 2013·Current Pain and Headache Reports·Oliver Summ, Stefan Evers
Jan 1, 1979·Drug Metabolism Reviews·D E Duggan, K C Kwan
Mar 1, 1983·Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism·T OkabeK Mortel
Jan 1, 1984·European Journal of Clinical Pharmacology·G N ChaudhariR D Kulkarni
Jan 1, 1989·European Journal of Clinical Pharmacology·A Van HeckenP J De Schepper
Jan 1, 1987·European Journal of Clinical Pharmacology·A MarzoA La Manna
Apr 22, 1982·The New England Journal of Medicine·E W SalzmanG Kurland

Related Concepts

Clinical Trials
Half-Life
Osmosin
Intravenous Injections
Intestinal Absorption
Chromatography, Gas-Liquid-Mass Spectrometry
Rectal Suppository

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Pediculosis pubis

Pediculosis pubis is a disease caused by a parasitic insect known as Pthirus pubis, which infests human pubic hair, as well as other areas with hair including eye lashes. Here is the latest research.

Rh Isoimmunization

Rh isoimmunization is a potentially preventable condition that occasionally is associated with significant perinatal morbidity or mortality. Discover the latest research on Rh Isoimmunization here.

Genetic Screens in iPSC-derived Brain Cells

Genetic screening is a critical tool that can be employed to define and understand gene function and interaction. This feed focuses on genetic screens conducted using induced pluripotent stem cell (iPSC)-derived brain cells. It also follows CRISPR-Cas9 approaches to generating genetic mutants as a means of understanding the effect of genetics on phenotype.

Enzyme Evolution

This feed focuses on molecular models of enzyme evolution and new approaches (such as adaptive laboratory evolution) to metabolic engineering of microorganisms. Here is the latest research.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Pharmacology of Proteinopathies

This feed focuses on the pharmacology of proteinopathies - diseases in which proteins abnormally aggregate (i.e. Alzheimer’s, Parkinson’s, etc.). Discover the latest research in this field with this feed.

Alignment-free Sequence Analysis Tools

Alignment-free sequence analyses have been applied to problems ranging from whole-genome phylogeny to the classification of protein families, identification of horizontally transferred genes, and detection of recombined sequences. Here is the latest research.